La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

RadNet Performance dei guadagni passati

Il passato criteri di controllo 2/6

Gli utili di RadNet sono diminuiti a un tasso medio annuo di -12.2%, mentre il settore Healthcare ha visto gli utili crescere a un tasso medio annuo di 7.1%. I ricavi sono cresciuti crescere a un tasso medio annuo di 9.8%. Il ritorno sul capitale proprio di RadNet è 3.9% e ha margini netti di 0.6%.

Informazioni chiave

-12.2%

Tasso di crescita degli utili

-16.0%

Tasso di crescita dell'EPS

Healthcare Crescita del settore	8.5%
Tasso di crescita dei ricavi	9.8%
Rendimento del capitale proprio	3.9%
Margine netto	0.6%
Ultimo aggiornamento sui guadagni	30 Jun 2024

Aggiornamenti sulle prestazioni recenti

Recent updates

An Intrinsic Calculation For RadNet, Inc. (NASDAQ:RDNT) Suggests It's 41% Undervalued

Nov 26

RadNet JV acquires Montclair Radiology's outpatient radiology assets

Oct 11

Some Investors May Be Worried About RadNet's (NASDAQ:RDNT) Returns On Capital

Oct 10

RadNet Presents With The Idiosyncratic Risk Premia To Deliver Risk-Adjusted Alpha

Aug 28

Here's Why RadNet (NASDAQ:RDNT) Has A Meaningful Debt Burden

Aug 12

RadNet Non-GAAP EPS of $0.15 beats by $0.06, revenue of $354.1M beats by $5.16M;reaffirms FY guidance

Aug 09

RadNet (NASDAQ:RDNT) Is Reinvesting At Lower Rates Of Return

Jul 01

Is It Time To Consider Buying RadNet, Inc. (NASDAQ:RDNT)?

Jun 17

Is RadNet (NASDAQ:RDNT) A Risky Investment?

May 11

Estimating The Intrinsic Value Of RadNet, Inc. (NASDAQ:RDNT)

Apr 06

Is RadNet (NASDAQ:RDNT) Using Too Much Debt?

Jan 24

Returns On Capital At RadNet (NASDAQ:RDNT) Have Stalled

Dec 23

Is RadNet, Inc. (NASDAQ:RDNT) Potentially Undervalued?

Dec 08

Ripartizione dei ricavi e delle spese

Come RadNet guadagna e spende denaro. In base agli ultimi utili dichiarati, su base LTM.

Storia dei guadagni e delle entrate

NasdaqGM:RDNT Ricavi, spese e utili (USD Millions )
Data	Ricavi	Guadagni	Spese G+A
30 Jun 24	1,714	10	142
31 Mar 24	1,658	21	142
31 Dec 23	1,617	3	142
30 Sep 23	1,580	4	141
30 Jun 23	1,528	-13	142
31 Mar 23	1,479	-13	173
31 Dec 22	1,430	11	144
30 Sep 22	1,382	8	92
30 Jun 22	1,365	23	61
31 Mar 22	1,344	18	0
31 Dec 21	1,324	25	0
30 Sep 21	1,297	35	108
30 Jun 21	1,256	24	55
31 Mar 21	1,138	11	81
31 Dec 20	1,098	-15	0
30 Sep 20	1,090	-10	106
30 Jun 20	1,091	-13	108
31 Mar 20	1,164	2	133
31 Dec 19	1,154	15	0
30 Sep 19	1,111	33	24
30 Jun 19	1,060	35	99
31 Mar 19	1,015	36	90
31 Dec 18	975	32	0
30 Sep 18	953	-4	85
30 Jun 18	939	-6	83
31 Mar 18	925	-6	59
31 Dec 17	922	0	0
30 Sep 17	912	11	77
30 Jun 17	909	9	74
31 Mar 17	897	7	75
31 Dec 16	885	7	74
30 Sep 16	875	5	75
30 Jun 16	859	11	76
31 Mar 16	845	11	74
31 Dec 15	810	8	72
30 Sep 15	779	11	70
30 Jun 15	755	7	68
31 Mar 15	730	9	66
31 Dec 14	718	1	64
30 Sep 14	710	-2	63
30 Jun 14	701	-7	63
31 Mar 14	699	-9	64
31 Dec 13	703	2	65
30 Sep 13	684	53	65

Guadagni di qualità: RDNT ha guadagni di alta qualità.

Margine di profitto in crescita: RDNT è diventata redditizia in passato.

Flusso di cassa libero e analisi degli utili

Analisi della crescita degli utili nel passato

Andamento degli utili: Gli utili di RDNT sono diminuiti del 12.2% all'anno negli ultimi 5 anni.

Accelerare la crescita: RDNT è diventata redditizia nell'ultimo anno, rendendo difficile confrontare il tasso di crescita degli utili con la media quinquennale.

Guadagni vs Settore: RDNT è diventata redditizia nell'ultimo anno, rendendo difficile confrontare la crescita dei suoi utili dell'anno passato con il settore Healthcare ( 6% ).

RadNet Performance dei guadagni passati

Il passato criteri di controllo 2/6

Informazioni chiave

Aggiornamenti sulle prestazioni recenti

First quarter 2024 earnings: EPS and revenues exceed analyst expectations

Full year 2023 earnings: EPS misses analyst expectations

Third quarter 2023 earnings: EPS and revenues exceed analyst expectations

Second quarter 2023 earnings: EPS and revenues exceed analyst expectations

Full year 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Third quarter 2022 earnings: EPS misses analyst expectations

Recent updates

RadNet (NASDAQ:RDNT) Seems To Use Debt Quite Sensibly

Returns On Capital At RadNet (NASDAQ:RDNT) Have Stalled

RadNet: Qualified Growth Route, Still Undervalued

Price target increased by 7.2% to US$57.17

Is There Now An Opportunity In RadNet, Inc. (NASDAQ:RDNT)?

First quarter 2024 earnings: EPS and revenues exceed analyst expectations

Now 23% overvalued after recent price rise

RadNet, Inc., Annual General Meeting, Jun 12, 2024

Price target increased by 7.0% to US$53.33

Are RadNet, Inc. (NASDAQ:RDNT) Investors Paying Above The Intrinsic Value?

Now 21% overvalued after recent price rise

RadNet, Inc. has completed a Follow-on Equity Offering in the amount of $200.2 million.

Consensus EPS estimates increase by 12%

RadNet, Inc.'s (NASDAQ:RDNT) 26% Price Boost Is Out Of Tune With Revenues

Price target increased by 12% to US$45.80

Now 21% overvalued after recent price rise

Full year 2023 earnings: EPS misses analyst expectations

Why RadNet, Inc. (NASDAQ:RDNT) Could Be Worth Watching

RadNet, Inc. Stock Price Is More Vigorous Than Its Valuation

Getting In Cheap On RadNet, Inc. (NASDAQ:RDNT) Might Be Difficult

Insider recently sold US$354k worth of stock

Insider notifies of intention to sell stock

RadNet, Inc. Launches a Pilot Inside Walmart of its New MammogramNow™ Offering

We Think RadNet (NASDAQ:RDNT) Can Stay On Top Of Its Debt

RadNet, Inc. Unveils DeepHealth, a Pioneering AI-Powered Health Informatics Portfolio

RadNet, Inc. Unveils DeepHealth, a Pioneering AI-Powered Health Informatics Portfolio

Third quarter 2023 earnings: EPS and revenues exceed analyst expectations

RadNet (NASDAQ:RDNT) Might Be Having Difficulty Using Its Capital Effectively

New major risk - Financial position

RadNet, Inc. Appoints Dr. Gregory Sorensen as Executive Vice President and Chief Science Officer

RadNet (NASDAQ:RDNT) Takes On Some Risk With Its Use Of Debt

Radnet, Inc. Revises Earnings Guidance for the Year 2023

Second quarter 2023 earnings: EPS and revenues exceed analyst expectations

RadNet, Inc. Announces Appointment of Executives

Consensus EPS estimates upgraded to US$0.10 loss

RadNet, Inc. has completed a Follow-on Equity Offering in the amount of $225.35625 million.

President & COO of Western Operations recently sold US$1.4m worth of stock

RadNet, Inc. Announces Ruth V. Wilson Did Not to Stand for Re-Election to the Board of Directors

President & COO of Western Operations exercised options to buy US$1.5m worth of stock.

RadNet, Inc., Annual General Meeting, Jun 07, 2023

Board Member recently sold US$138k worth of stock

RadNet, Inc. Revises Earnings Guidance for the Year 2023

Price target increased by 7.8% to US$34.50

We Think RadNet (NASDAQ:RDNT) Is Taking Some Risk With Its Debt

President & COO of Eastern Operations recently sold US$230k worth of stock

Insider recently sold US$443k worth of stock

Full year 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

RadNet (NASDAQ:RDNT) Will Want To Turn Around Its Return Trends

Radiology Imaging Associates Launches the Enhanced Breast Cancer Detection Program, Providing Women A New State-Of-The-Art Solution Powered by Artificial Intelligence

President & COO of Western Operations recently sold US$97k worth of stock

RadNet (NASDAQ:RDNT) Has A Somewhat Strained Balance Sheet

An Intrinsic Calculation For RadNet, Inc. (NASDAQ:RDNT) Suggests It's 41% Undervalued

Consensus forecasts updated

Third quarter 2022 earnings: EPS misses analyst expectations

RadNet, Inc. Provides Earnings Guidance for the Full Year of 2022

Investor sentiment deteriorated over the past week

RadNet, Inc. (NasdaqGM:RDNT) acquired 75% stake in Heart & Lung Imaging Limited.

RadNet JV acquires Montclair Radiology's outpatient radiology assets

Some Investors May Be Worried About RadNet's (NASDAQ:RDNT) Returns On Capital

Price target decreased to US$32.25

Investor sentiment improved over the past week